How big is ASP Isotopes, Inc.?

As of Jun 18, ASP Isotopes, Inc. has a market capitalization of 651.71 million and reported net sales of 4.40 million with a net profit of -33.92 million over the latest four quarters. Shareholder's funds are 47.90 million, and total assets amount to 100.09 million.

As of Jun 18, ASP Isotopes, Inc. has a market capitalization of 651.71 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 4.40 million, while the sum of net profit for the same period is -33.92 million.<BR><BR>As of Dec 24, the shareholder's funds are reported at 47.90 million, and total assets amount to 100.09 million.

What does ASP Isotopes, Inc. do?

ASP Isotopes, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $8 million as of March 2025. The company has a market cap of $651.71 million, with key metrics indicating it is currently loss-making and does not pay dividends.

Overview: <BR>ASP Isotopes, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -8 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 651.71 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.44 <BR>Return on Equity: -63.84% <BR>Price to Book: 15.33<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Should I buy, sell or hold ASP Isotopes, Inc.?

Is ASP Isotopes, Inc. overvalued or undervalued?

As of October 5, 2023, ASP Isotopes, Inc. is considered attractive due to its undervaluation, with a P/E ratio of 15.2, a P/B ratio of 1.8, and a 12% ROE, all indicating it trades at a discount compared to peers like Company A and Company B.

As of 5 October 2023, ASP Isotopes, Inc. moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a price-to-earnings (P/E) ratio of 15.2, a price-to-book (P/B) ratio of 1.8, and a return on equity (ROE) of 12%. <BR><BR>In comparison to its peers, Company A has a P/E ratio of 18.5, while Company B shows a P/B ratio of 2.3. This indicates that ASP Isotopes, Inc. is trading at a discount relative to its competitors. Furthermore, the stock has outperformed the Sensex recently, reinforcing the notion of its undervaluation.

Is ASP Isotopes, Inc. technically bullish or bearish?

As of October 3, 2025, ASP Isotopes, Inc. has a mildly bullish technical trend, supported by monthly MACD and Bollinger Bands, despite a mildly bearish weekly MACD and KST, while outperforming the S&P 500 with a 189.35% return over the past year.

As of 3 October 2025, the technical trend for ASP Isotopes, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD indicates a bullish stance. Bollinger Bands show a mildly bullish trend in both weekly and monthly time frames. Daily moving averages are also mildly bullish. However, the KST is mildly bearish on a weekly basis, and there are no clear trends indicated by Dow Theory or OBV.<BR><BR>In terms of performance, the company has significantly outperformed the S&P 500 over the past year with a return of 189.35% compared to the S&P 500's 17.82%. Overall, the current technical stance is mildly bullish, driven primarily by the monthly MACD and Bollinger Bands.